Aster DM Healthcare Limited

Key metrics

Price as of 2026-07-17

Stock price

₹819.90

Market cap

42,481 Cr

Stock P/E

108.3

P/B

8.79

Dividend yield

0.1%

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly · ₹ Cr · tap + rows to expand

Metric	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026
Sales	3,215 Cr	6,532 Cr	10,243 Cr	3,699 Cr	1,002 Cr	2,088 Cr	1,050 Cr	1,000 Cr	1,078 Cr	1,197 Cr	1,186 Cr	1,182 Cr
Operating expenses (approx.)	2,818 Cr	5,804 Cr	8,942 Cr	3,096 Cr	790 Cr	1,621 Cr	884 Cr	803 Cr	842 Cr	919 Cr	975 Cr	913 Cr
EBITDA	397 Cr	728 Cr	1,300 Cr	603 Cr	212 Cr	467 Cr	165 Cr	197 Cr	236 Cr	278 Cr	211 Cr	269 Cr
OPM %	12.3%	11.1%	12.7%	16.3%	21.2%	22.4%	15.8%	19.7%	21.9%	23.2%	17.8%	22.8%
Other income	9 Cr	18 Cr	26 Cr	25 Cr	49 Cr	84 Cr	33 Cr	31 Cr	33 Cr	28 Cr	28 Cr	36 Cr
Interest	99 Cr	201 Cr	299 Cr	110 Cr	29 Cr	61 Cr	31 Cr	32 Cr	31 Cr	31 Cr	31 Cr	30 Cr
Depreciation	217 Cr	445 Cr	676 Cr	220 Cr	60 Cr	123 Cr	62 Cr	64 Cr	63 Cr	66 Cr	68 Cr	67 Cr
Profit before tax	81 Cr	83 Cr	325 Cr	273 Cr	123 Cr	284 Cr	105 Cr	101 Cr	142 Cr	181 Cr	112 Cr	172 Cr
Tax %	66.3%	76.9%	27.1%	20.7%	31.8%	32.4%	35.5%	5.0%	30.2%	25.2%	39.7%	5.7%
Net profit	20 Cr	5 Cr	214 Cr	212 Cr	5,152 Cr	5,258 Cr	64 Cr	86 Cr	94 Cr	121 Cr	59 Cr	154 Cr
EPS (₹)	₹0.10	₹-0.52	₹3.08	₹2.60	₹103.34	₹105.27	₹1.14	₹1.59	₹1.67	₹2.13	₹1.02	₹2.72

Annual · last column is TTM · ₹ Cr · tap + to expand

Metric	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	7,963 Cr	8,739 Cr	8,608 Cr	10,253 Cr	11,933 Cr	3,699 Cr	4,138 Cr	4,643 Cr	Sign in for TTM
Operating expenses (approx.)	7,067 Cr	7,463 Cr	7,496 Cr	8,719 Cr	10,368 Cr	3,121 Cr	3,276 Cr	3,649 Cr	Sign in for TTM
EBITDA	896 Cr	1,276 Cr	1,113 Cr	1,534 Cr	1,565 Cr	578 Cr	863 Cr	994 Cr	Sign in for TTM
OPM %	11.3%	14.6%	12.9%	15.0%	13.1%	15.6%	20.8%	21.4%	Sign in for TTM
Other income	35 Cr	38 Cr	50 Cr	51 Cr	78 Cr	25 Cr	148 Cr	126 Cr	Sign in for TTM
Interest	179 Cr	360 Cr	294 Cr	257 Cr	329 Cr	110 Cr	124 Cr	123 Cr	Sign in for TTM
Depreciation	306 Cr	586 Cr	618 Cr	641 Cr	780 Cr	220 Cr	249 Cr	264 Cr	Sign in for TTM
Profit before tax	411 Cr	330 Cr	202 Cr	636 Cr	534 Cr	273 Cr	490 Cr	607 Cr	Sign in for TTM
Tax %	10.5%	4.7%	13.5%	5.6%	11.2%	20.7%	27.4%	23.5%	Sign in for TTM
Net profit	367 Cr	315 Cr	178 Cr	601 Cr	475 Cr	212 Cr	5,408 Cr	427 Cr	Sign in for TTM
EPS (₹)	₹6.63	₹5.51	₹2.97	₹10.58	₹8.54	₹2.60	₹107.98	₹7.53	Sign in for TTM
Dividend payout %	—	—	—	3.4%	5.7%	8.5%	114.2%	12.9%	Sign in for TTM

Trailing twelve months totals and margin rows

Annual · ₹ Cr · tap + rows to expand

Metric	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	505 Cr	500 Cr	497 Cr	497 Cr	500 Cr	500 Cr	500 Cr	518 Cr
Reserves	2,709 Cr	2,773 Cr	2,875 Cr	3,456 Cr	3,949 Cr	4,060 Cr	2,580 Cr	3,709 Cr
Borrowings	—	—	—	—	2,287 Cr	669 Cr	158 Cr	143 Cr
Other liabilities	5,723 Cr	9,166 Cr	8,271 Cr	8,593 Cr	7,733 Cr	12,292 Cr	2,796 Cr	3,136 Cr
Total liabilities	8,936 Cr	12,438 Cr	11,643 Cr	12,546 Cr	14,881 Cr	17,991 Cr	6,606 Cr	8,112 Cr
Fixed assets (net)	—	—	—	—	4,629 Cr	2,880 Cr	3,628 Cr	2,619 Cr
CWIP	—	—	—	—	255 Cr	170 Cr	291 Cr	413 Cr
Investments	—	—	—	—	80 Cr	17 Cr	14 Cr	973 Cr
Other assets	—	—	—	—	4,922 Cr	565 Cr	1,901 Cr	1,948 Cr
Total assets	8,936 Cr	12,438 Cr	11,643 Cr	12,546 Cr	14,881 Cr	17,991 Cr	6,606 Cr	8,112 Cr

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

Metric	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	—	—	—	1,313 Cr	1,834 Cr	158 Cr	425 Cr	656 Cr
Cash from investing	—	—	—	-570 Cr	-972 Cr	-885 Cr	6,015 Cr	-288 Cr
Cash from financing	—	—	—	-685 Cr	-817 Cr	1,053 Cr	-6,358 Cr	-304 Cr
Net cash flow	—	—	—	58 Cr	45 Cr	326 Cr	82 Cr	63 Cr
Free cash flow (OCF − Capex)	—	—	—	830 Cr	1,117 Cr	-639 Cr	79 Cr	187 Cr

Ratios as reported or derived per annual period.

Metric	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROCE %	18.3%	21.1%	14.7%	22.6%	11.0%	6.3%	16.1%	14.7%
ROE %	10.4%	8.5%	4.4%	13.3%	8.7%	2.6%	147.3%	8.0%
Debtor days	—	—	—	—	71	23	—	—
Inventory days	—	—	—	—	40	11	8	7
Days payable	—	—	—	—	91	45	—	—
Cash conversion cycle	—	—	—	—	20	-11	8	7
Debt / equity	—	—	—	—	0.51	0.15	0.04	0.03
Current ratio	—	—	—	—	1.06	0.65	2.16	1.99
Net debt / EBITDA	0.00	0.00	0.00	0.00	1.22	1.02	-0.0071	-0.09

Loading peers…